Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were…
Communiqué de presse : Présentation de dernière heure de données pivots positives sur le Dupixent dans le traitement de la pemphigoïde bulleuse à l’AAD
Présentation de dernière heure de données pivots positives sur le Dupixent dans le traitement de la pemphigoïde bulleuse à l’AAD Cinq fois plus d’adultes traités par Dupixent présentaient une rémission…
Ultralife Corporation Files Form 12b-25 Notification of Late Filing
NEWARK, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI), today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange…
Rail Vision Receives Nasdaq Notification Regarding Minimum Bid Requirements
Ra’anana, Israel, March 07, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (the “Company”) (Nasdaq: RVSN), a technology company at the forefront of revolutionizing railway safety and the data-related market, announced…
Brilliant Earth Announces Participation in UBS Global Consumer and Retail Conference
SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced…
PDF Solutions Completes Acquisition of secureWISE, LLC
SANTA CLARA, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (NASDAQ: PDFS), today announced it has closed the acquisition of secureWISE, LLC, a widely used secure, remote connectivity…
Oncternal Therapeutics Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT) (the “Company”) today announced its intention to file a Form 25 Notification of Delisting with the Securities…
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement…
Former Congressman George Holding Joins Trump Media Board
Holding Fills Vacancy Left by Education Secretary Linda McMahon SARASOTA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Trump Media and Technology Group Corp. (Nasdaq: DJT)…
Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion Panel
WARREN, N.J., March 07, 2025 (GLOBE NEWSWIRE) -- Mittul Mehta, Chief Information Officer & Head of Tevogen.AI at Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage…